BIOMERIEUX/ FR0013280286 /
| 2024-11-12 3:30:17 PM | Chg. -0.10 | Volume | Bid5:30:09 PM | Ask5:30:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 103.40EUR | -0.10% | 0 Turnover: - |
-Bid Size: - | -Ask Size: - | 12.19 bill.EUR | 0.83% | 33.99 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.03 EUR | -21.09% |
| EPS Diluted: | - EUR | -21.20% |
| Revenues per Share: | 31.05 EUR | 2.39% |
| Book Value per Share: | 31.70 EUR | 3.00% |
| Cash Flow per Share: | 3.76 EUR | -6.25% |
| Dividend per Share: | 0.85 EUR | 0.00% |
| Total | in mill. | |
| Revenues: | 3,674.70 EUR | 2.39% |
| Net Income: | 357.60 EUR | -20.95% |
| Operating Cash Flow: | 445.40 EUR | - |
| Cash and Cash Equivalents: | 352.40 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 33.99 | 33.20 |
| P/S Ratio: | 3.32 | 3.24 |
| P/BV ratio: | 3.25 | 3.17 |
| P/CF Ratio: | 27.37 | 26.73 |
| PEG: | -1.61 | -1.57 |
| Earnings Yield: | 2.94% | 3.01% |
| Dividend Yield: | 0.83% | 0.84% |
| Market Capitalization | ||
| Market Capitalization: | 12.19 bill. EUR | 11.91 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 118.36 mill. | |
Profitability
| Gross Profit Margin: | 55.99% |
| EBIT Margin: | 11.95% |
| Net Profit Margin: | 9.73% |
| Return on Equity: | 9.53% |
| Return on Assets: | 6.80% |
Financial Strength
| Liquidity I / Cash Ratio: | 32.41% |
| Liquidity II / Quick Ratio: | 99.42% |
| Liquidity III / Current Ratio: | 202.81% |
| Debt / Equity Ratio: | 40.16% |
| Dynam. Debt / Equity Ratio: | 338.35% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
